Patent Problems for Roche's HIV Drug

by Rajshri on  May 6, 2010 at 9:29 PM AIDS/HIV News
RSS Email Print This Page Comment bookmark
Font : A-A+

Leading pharmaceutical company, Roche received a fresh blow after the Indian Patent Office in Chennai has granted a stay on the patent it had awarded to the company's HIV-related drug Valganciclovir.
 Patent Problems for Roche's HIV Drug
Patent Problems for Roche's HIV Drug

The Patent Office had originally awarded the patent back in 2007 without hearing objection of Indian Network for People Living with HIV/AIDS and Tamil Nadu Networking People with HIV/AIDS.

The decision was challenged both in the Madras High Court and the Supreme Court forcing the Patent Office to reject the patent by claiming that it "lacked an inventive step and did not satisfy the requirement of showing increased therapeutic efficacy as required under Section 3(d) of the Patent Law".

Meanwhile Roche has gone on the offensive and has filed a patent infringement case against Cipla, which is manufacturing a generic version of the drug. 


Source: Medindia
RAS

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Oral Health And AIDS Drug Toxicity AIDS/HIV AIDS/HIV - Epidemiology AIDS/HIV - Clinical Features AIDS/HIV - Health Education AIDS/HIV - Prevention And Transmission AIDS / HIV - Treatment AIDS/HIV- Lab Tests and Faqs Signature Drug Toxicity 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive

Loading...